Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis (Q36401243)

14 August 2017

1 reference

title

Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis (English)

1 reference

14 August 2017

0 references

Houman Ashrafian

1

0 references

language of work or name

English

0 references

publication date

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

367

1 reference

14 August 2017

9510

1 reference

14 August 2017

618-621

1 reference

Lessons from hereditary colorectal cancer

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

1 reference

7 January 2021

Cancer: crime and punishment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Glycogen debranching enzyme association with beta-subunit regulates AMP-activated protein kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Activating AMP-activated protein kinase without AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Why do cancers have high aerobic glycolysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Dysregulation of the TSC-mTOR pathway in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Estimation of glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Glycogen storage disease I and hepatocellular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Hyperglycemia, obesity, and cancer risks on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Effects of energy balance on cancer in genetically altered mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968228-7

7 January 2021

10.1016/S0140-6736(06)68228-7

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16488806